US 7271179
Inhibitors of JAK protein kinase
granted A61KA61K31/4709A61K31/517
Quick answer
US patent 7271179 (Inhibitors of JAK protein kinase) held by Vertex Pharmaceuticals Incorporated expires Mon Sep 13 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Sep 18 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 13 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61K, A61K31/4709, A61K31/517, A61K31/519, A61P